LABU Holdings Information

LABU is an equity ETF with a total of 150 individual holdings.

Total Holdings

Top 10 Percentage

88.74%

Asset Class

Equity

ETF Category

Trading--Leveraged Equity

Assets

747.34M

PE Ratio

n/a

Sector Allocation

No.	Symbol	Name	% Weight	Shares
1	n/a	S&P Biotechnology Select Industry Index Swap	24.24%	73,635
2	n/a	Goldman Finl Sq Trsry Inst 506	12.59%	97,687,721
3	n/a	Goldman Sachs Fin Gov 465 Institut	11.90%	92,311,150
4	n/a	S&P Biotechnology Select Industry Index Swap	8.83%	25,717
5	n/a	Dreyfus Govt Cash Man Ins	8.46%	65,631,137
6	n/a	S&P Biotechnology Select Industry Index Swap	8.39%	36,207
7	n/a	S&P Biotechnology Select Industry Index Swap	7.98%	35,845
8	n/a	S&P Biotechnology Select Industry Index Swap	2.76%	22,507
9	n/a	S&P Biotechnology Select Industry Index Swap	1.88%	15,133
10	RNA	Avidity Biosciences, Inc.	1.70%	188,627
11	RVMD	Revolution Medicines, Inc.	1.50%	195,537
12	INSM	Insmed Incorporated	1.44%	59,972
13	EXAS	Exact Sciences Corporation	1.38%	159,801
14	CRSP	CRISPR Therapeutics AG	1.34%	167,764
15	INCY	Incyte Corporation	1.33%	101,478
16	BBIO	BridgeBio Pharma, Inc.	1.32%	165,261
17	NTRA	Natera, Inc.	1.32%	51,549
18	REGN	Regeneron Pharmaceuticals, Inc.	1.30%	15,744
19	IONS	Ionis Pharmaceuticals, Inc.	1.30%	136,755
20	ROIV	Roivant Sciences Ltd.	1.29%	509,344
21	UTHR	United Therapeutics Corporation	1.25%	22,079
22	VRTX	Vertex Pharmaceuticals Incorporated	1.24%	22,524
23	AMGN	Amgen Inc.	1.20%	31,426
24	BIIB	Biogen Inc.	1.20%	61,369
25	GILD	Gilead Sciences, Inc.	1.19%	75,937

Showing 25 of 150 holdings

Get a Stock Analysis Pro account to see the full list of holdings and get unlimited access to all data and tools.

As of Nov 3, 2025